Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Process-based pharmacology in neuroanesthesia.

D J Stone1

  • 1Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottsville, VA 22908-0710, USA. djs4v@Virginia.edu

Current Opinion in Anaesthesiology
|October 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease.

The pharmacogenomics journal·2009
Same author

The novel, orally active, delta opioid RWJ-394674 is biotransformed to the potent mu opioid RWJ-413216.

The Journal of pharmacology and experimental therapeutics·2006
Same author

A quantitative genomic expression analysis platform for multiplexed in vitro prediction of drug action.

The pharmacogenomics journal·2005
Same author

Differential tramadol and O-desmethyl metabolite levels in brain vs. plasma of mice and rats administered tramadol hydrochloride orally.

Journal of clinical pharmacy and therapeutics·2002
Same author

Effects of pre- and postnatal corticosterone exposure on the rat hippocampal GABA system.

Hippocampus·2001
Same author

Gas chromatographic method using nitrogen-phosphorus detection for the measurement of tramadol and its O-desmethyl metabolite in plasma and brain tissue of mice and rats.

Journal of chromatography. B, Biomedical sciences and applications·2001
Same journal

The evolution of nonoperating room anesthesia: navigating a new frontier.

Current opinion in anaesthesiology·2026
Same journal

Enhanced recovery pathways for patients with chronic pain: beyond standard protocols - a narrative review.

Current opinion in anaesthesiology·2026
Same journal

Novel technologies and innovations in postoperative follow-up after regional anesthesia.

Current opinion in anaesthesiology·2026
Same journal

Regional anaesthesia and analgesia in surgical patients with chronic preoperative pain: mechanisms, evidence, and clinical implications.

Current opinion in anaesthesiology·2026
Same journal

Retention in pain care and research: a narrative review focused on implanted medical devices.

Current opinion in anaesthesiology·2026
Same journal

Airway ultrasound in patients undergoing head and neck surgery.

Current opinion in anaesthesiology·2026
See all related articles

This review covers intravenous pharmacologic agents for managing surgical complications like high intracranial pressure and controlled hypertension. It balances old and new data for effective patient care during neurosurgery.

Area of Science:

  • Anesthesiology
  • Neurosurgery
  • Pharmacology

Background:

  • Surgical procedures can present complex challenges, including managing elevated intracranial pressure (ICP) due to tumor or trauma.
  • Specific neurosurgical interventions, such as those involving previously ruptured aneurysms or requiring controlled hypertension (e.g., carotid endarterectomy, temporary clipping), necessitate careful pharmacologic management.
  • Intravenous agents are crucial for addressing these perioperative complications, distinct from inhaled anesthetics or neuromuscular blockers.

Purpose of the Study:

  • To review the application of selected pharmacologic agents in managing specific surgical complications.
  • To provide a balanced perspective integrating established data, recent findings, and clinical experience.
  • To focus on intravenous anesthetic agents relevant to neurosurgical and cerebrovascular procedures.

Related Experiment Videos

Main Methods:

  • Literature review synthesizing older established data and newer information.
  • Analysis of clinical practice guidelines and long-term patient care strategies.
  • Focus on intravenous pharmacologic agents, excluding neuromuscular blockers and inhaled agents.

Main Results:

  • Identification of key intravenous agents for managing elevated ICP in trauma and tumor patients.
  • Evaluation of pharmacologic strategies for patients with ruptured aneurysms.
  • Assessment of agents used to achieve controlled hypertension during procedures like carotid endarterectomy.
  • Discussion of the balance between efficacy, safety, and clinical applicability of different agents.

Conclusions:

  • Intravenous pharmacologic agents play a vital role in managing critical neurosurgical and cerebrovascular complications.
  • A comprehensive understanding of both historical and current data is essential for optimal perioperative management.
  • Clinical practice should integrate evidence-based strategies for safe and effective patient outcomes during complex surgeries.